René Ernst N.
- Country
- Denmark
- Department
- Department of Psychiatry
Research Overview
- Efficacy and Safety of Psilocybin (COMP360) in Adults with Treatment-Resistant Depression: A Phase III Randomized, Double-Blind, Controlled Trial
- Long-term Safety Evaluation of Iclepertin in Schizophrenia Patients Post-Completion of Phase III Trials
- Comparative Efficacy of Lithium and Cariprazine in Acute Bipolar Depression: A Randomized, Open-Label, Multicenter Study
Data & Insights
Has run more than one trial at 37 of 137 partner sites.
Specializations
Depression and Mood Disorders
This investigator specializes in treating complex manifestations of treatment-resistant depression and bipolar disorder, with particular attention to innovative therapeutic approaches.
- Treatment-resistant depression management
- Bipolar depression interventions
- Novel therapeutic compounds
The research encompasses both traditional and emerging treatment modalities for mood disorders.
Schizophrenia Research
The investigator focuses on multiple aspects of schizophrenia treatment, including cognitive impairment and comorbid conditions.
- Cognitive dysfunction in schizophrenia
- Long-term treatment outcomes
- Novel antipsychotic interventions
Their work addresses both core symptoms and associated cognitive challenges in schizophrenia.
Dual Diagnosis Treatment
The investigator has particular expertise in treating concurrent psychiatric and substance use disorders, specifically focusing on alcohol use disorder in psychiatric populations.
- Integrated treatment approaches
- Alcohol use disorder in schizophrenia
- Innovative therapeutic interventions
Their research explores targeted treatments for complex dual diagnosis presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.